18 May 2023
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
Sponsored by Abbott
Anchorperson:
R. S. von Bardeleben
Spokesperson:
F. Maisano
Summary
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
Learning Objectives
- To learn how patient selection and timely interventions improve patient prognosis
- To understand why mitral regurgitation mild or less adds efficacy to TEER
- To appreciate the now proven durability in mitral valve transcatheter repair and replacement: cumulative evidence after two decades of experience and perspectives for the future
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide000.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)